CXCL12 and Miyoshi myopathy: Data collected from 12 independent experiments performed on U266, RPMI8226 and primary MM cells revealed that WEV and WEV+NP treatments significantly reduced the CXCL12-mediated chemotaxis of MM cells (Figure 3D).